Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 26;7(10):ofaa412.
doi: 10.1093/ofid/ofaa412. eCollection 2020 Oct.

Diabetic Foot Infections: Local Prevalence of and Case-Control Study of Risk Factors for Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa

Justin J Kim  1 , Alison Lydecker  2 , Rohini Davé  3 , Jacqueline T Bork  4   5 , Mary-Claire Roghmann  2   6
Affiliations
Free PMC article

Diabetic Foot Infections: Local Prevalence of and Case-Control Study of Risk Factors for Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa

Justin J Kim et al. Open Forum Infect Dis. .
Free PMC article

Abstract

We identified deep diabetic foot infections by culture and conducted a case-control study examining the risk factors for moderate to severe methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa (PsA) diabetic foot infections. Our MRSA prevalence was lower than literature values; PsA was higher. Gangrene may be predictive of Pseudomonas infection.

Keywords: MRSA; Pseudomonas aeruginosa; case–control study; diabetic foot infection.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Lipsky BA, Berendt AR, Cornia PB, et al. ; Infectious Diseases Society of America 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012; 54:e132–73. - PubMed
    1. Hindler JF, Stelling J. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute. Clin Infect Dis 2007; 44:867–73. - PubMed
    1. Eleftheriadou I, Tentolouris N, Argiana V, et al. Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs 2010; 70:1785–97. - PubMed
    1. Reveles KR, Duhon BM, Moore RJ, et al. Epidemiology of methicillin-resistant Staphylococcus aureus diabetic foot infections in a large academic hospital: implications for antimicrobial stewardship. PLoS One 2016; 11:e0161658. - PMC - PubMed
    1. Farkas A, Lin F, Bui K, et al. Development of predictive nomograms for clinical use to quantify the risk of isolating resistance prone organisms in patients with infected foot ulcers. Epidemiol Infect 2019; 147:e157. - PMC - PubMed